Register entry

WAVELENGTH ENTERPRISES LTD

Data as of · How to read this entry

Registered sites
1
Active NDC listings
47
Labeller names
4
Live patents
0
Countries
1
Base
Israel
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
WAVELENGTH ENTERPRISES LTDEco-Industrial Park, Neot-Hovav, Southern District 8551600, Israel (ISR)Analytical testing, Active ingredient (API) manufacture3002806718600077101
Catalogue

Drug listings by form and route

47

47 active NDC listings: 47 bulk ingredient. By marketing category: BULK INGREDIENT 47.

Dosage formNDCs
powder46
liquid1
RouteNDCs
Labeller name on the listingNDCs
wavelength enterprises ltd32
wavelength enterprises ltd8
wavelength enterprises ltd.6
wavelength enterprises ltd1
Catalogue

Marketed products

47
BrandGeneric nameForm / routeNDC
-CANTHARIDINpowder58175-0642BULK INGREDIENT
-CLASCOTERONEpowder58175-0650BULK INGREDIENT
-Crisaborolepowder58175-0622BULK INGREDIENT
-D9-Tetrahydrocannabinol-Naphthoylesterpowder58175-0644BULK INGREDIENT
-Donepezil HClpowder58175-0557BULK INGREDIENT
-GANAXOLONEpowder58175-0654BULK INGREDIENT
-GRANISETRON HYDROCHLORIDEpowder58175-0360BULK INGREDIENT
-Glycopyrronium Bromidepowder58175-0624BULK INGREDIENT
-MOMETASONE FUROATEpowder58175-1234BULK INGREDIENT
-MOMETASONE FUROATE MONOHYDRATEpowder58175-0551BULK INGREDIENT
-NALTREXONE HYDROCHLORIDEpowder58175-0632BULK INGREDIENT
-Naltrexone Basepowder58175-0628BULK INGREDIENT
-OMEPRAZOLE MAGNESIUMpowder58175-0559BULK INGREDIENT
-PALONOSETRON HYDROCHLORIDEpowder58175-0543BULK INGREDIENT
-PODOFILOXpowder58175-0664BULK INGREDIENT
-Pralidoxime Chloridepowder58175-0640BULK INGREDIENT
-REMIMAZOLAM BESYLATEpowder58175-0648BULK INGREDIENT
-ROTIGOTINEpowder58175-0545BULK INGREDIENT
-SITAGLIPTIN PHOSPHATEpowder58175-0620BULK INGREDIENT
-SITAGLIPTIN PHOSPHATE MONOHYDRATEpowder58175-0638BULK INGREDIENT
-Sugammadexpowder58175-0618BULK INGREDIENT
-Tapinarofpowder58175-0646BULK INGREDIENT
-Tiotropium Bromidepowder58175-0565BULK INGREDIENT
-UMECLIDINIUM BROMIDEpowder58175-0626BULK INGREDIENT
-cetirizine hydrochloridepowder58175-0370BULK INGREDIENT
-cilostazolpowder58175-0379BULK INGREDIENT
-cisatracurium besylatepowder58175-0541BULK INGREDIENT
-donepezil basepowder58175-0549BULK INGREDIENT
-efinaconazolepowder58175-0606BULK INGREDIENT
-fenofibratepowder58175-0348BULK INGREDIENT
-fexofenadine hydrochloridepowder58175-0616BULK INGREDIENT
-flumazenilpowder58175-0365BULK INGREDIENT
-fluticasone furoatepowder58175-0553BULK INGREDIENT
-fluticasone propionatepowder58175-0361BULK INGREDIENT
-fulvestrantpowder58175-0600BULK INGREDIENT
-granisetron basepowder58175-0537BULK INGREDIENT
-halobetasol propionatepowder58175-0391BULK INGREDIENT
-ibrutinibpowder58175-0602BULK INGREDIENT
-imiquimodpowder58175-0397BULK INGREDIENT
-midazolam basepowder58175-0350BULK INGREDIENT
-modafinilpowder58175-0378BULK INGREDIENT
-permethrinliquid58175-0604BULK INGREDIENT
-pramipexole dihydrochloride monohydratepowder58175-0407BULK INGREDIENT
-rocuronium bromidepowder58175-0395BULK INGREDIENT
-tavaborolepowder58175-0614BULK INGREDIENT
-temozolomidepowder58175-0411BULK INGREDIENT
-tramadol hclpowder58175-0364BULK INGREDIENT
Compare

Comparable companies in Israel

Enquiry

Common questions

Is WAVELENGTH ENTERPRISES LTD FDA approved?
WAVELENGTH ENTERPRISES LTD holds 1 FDA-registered establishment in Israel. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are WAVELENGTH ENTERPRISES LTD's drugs manufactured?
The FDA register lists Neot-Hovav. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does WAVELENGTH ENTERPRISES LTD make?
47 products are listed under WAVELENGTH ENTERPRISES LTD in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.